CClinicalTrials.gg
CompletedNCT02828371Updated Jul 11, 2016

Early Stepping Verticalization in ICU for ABI Patients

An interventional study of stepping verticalization and conventional mobilization in Brain Injury and Consciousness Disorders, sponsored by Ospedale Generale Di Zona Moriggia-Pelascini. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-07-11.

Sponsored by Ospedale Generale Di Zona Moriggia-Pelascini · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Verticalization was reported to improve the level of arousal and awareness in patients with severe acquired brain injury (ABI) and to be safe in ICU. The investigators evaluated the effectiveness of a very early stepping verticalization protocol on the functional and neurological outcome of patients affected by disorder of consciousness due to ABI.

Consecutive patients with Vegetative State or Minimally Conscious State were enrolled in ICU on the third day after an ABI. They were randomized to undergo conventional physiotherapy alone or associated to fifteen 30-minute sessions of verticalization, using a tilt table with robotic stepping device. Once stabilized, patients were transferred to a Neurorehabilitation unit for an individualized treatment. Outcome measures were assessed on the third day from the injury (T0), at ICU discharge (T1) and at Rehab discharge (T2).

02

Conditions studied

  • Brain Injury
  • Consciousness Disorders
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's enrollment of 40 is below the median of 48 across 1,331 interventional studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

Ospedale Generale Di Zona Moriggia-Pelascini is the lead sponsor of 36 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Glasgow Coma Scale (GCS) ≤8 for ≥24h from the event;
  • diagnosis of vegetative state or minimally conscious state on the third day after the injury;
  • adequate pulmonary gas exchanging function;
  • stable hemodynamics

Exclusion criteria

Exclusion Criteria:

  • sedation;
  • unstable intracranial pressure (ICP);
  • cerebral perfusion pressure (CPP) \<60 mmHg;
  • fractures or skin lesions in thorax, abdomen or lower limbs;
  • deep vein thrombosis;
  • body weight >130 kg; height >210 cm.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Erigo

    Single daily sessions of verticalization, using a tilt table with an integrated robotic stepping device (Erigo. Hocoma AG, Switzerland) located in the ICU room. Sessions were performed five times per week (Monday-Friday) for three consecutive weeks (a total of 15 sessions per patient). On the same days the patients received conventional physiotherapy for 30 minutes a day. Before the verticalization period the experimental group received conventional in-bed physiotherapy for 60 minutes a day.

    Device: stepping verticalization

  • Active comparator
    Conventional

    treated with conventional in-bed physiotherapy for 60 minutes a day, from Monday to Friday, throughout the ICU stay.

    Other: conventional mobilization

Interventions

  • Devicestepping verticalization

    After patient positioning, the slope of the tilt table was gradually increased from 0° to 20°, 40° and then 60° in a time span of nine minutes. The stepping frequency was set at 20 steps/min for the entire treatment. Cardiovascular and respiratory parameters were continuously monitored. The net time of the session was 30 minutes

  • Otherconventional mobilization

    in-bed physiotherapy (mobilization exercises in supine and sitting position on bed, without out-of-bed mobilization nor verticalization)

06

What researchers measure

Primary outcomes

  1. Coma Recovery Scale change

    Time frame: through study completion, average 18 weeks

  2. Glasgow Coma Scale change

    Time frame: through study completion, average 18 weeks

  3. Levels of Cognitive Functioning change

    Time frame: through study completion, average 18 weeks

  4. Disability Rating Scale change

    Time frame: through study completion, average 18 weeks

07

Study locations

1 site
  • Ospedale Generale di Zona "Moriggia Pelascini"
    Gravedona ed Uniti, CO 22015, Italy
08

References and documents

Publications

  • Frazzitta G, Zivi I, Valsecchi R, Bonini S, Maffia S, Molatore K, Sebastianelli L, Zarucchi A, Matteri D, Ercoli G, Maestri R, Saltuari L. Effectiveness of a Very Early Stepping Verticalization Protocol in Severe Acquired Brain Injured Patients: A Randomized Pilot Study in ICU. PLoS One. 2016 Jul 22;11(7):e0158030. doi: 10.1371/journal.pone.0158030. eCollection 2016. PubMed 27447483 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02828371
Lead sponsor
Ospedale Generale Di Zona Moriggia-Pelascini
Responsible party
Ilaria Zivi (MD, Ospedale Generale Di Zona Moriggia-Pelascini) — Principal investigator
First posted
Jul 11, 2016
Start date
Jan 2015
Primary completion
Nov 2015
Completion
Dec 2015
Last update
Jul 11, 2016
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion